Biofrontera Depreciation vs Net Income Analysis

BFRIW Stock  USD 0.05  0.0001  0.22%   
Biofrontera Warrants financial indicator trend analysis is way more than just evaluating Biofrontera Warrants prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Biofrontera Warrants is a good investment. Please check the relationship between Biofrontera Warrants Depreciation and its Net Income accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biofrontera Warrants. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
For more information on how to buy Biofrontera Stock please use our How to Invest in Biofrontera Warrants guide.

Depreciation vs Net Income

Depreciation vs Net Income Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Biofrontera Warrants Depreciation account and Net Income. At this time, the significance of the direction appears to have very week relationship.
The correlation between Biofrontera Warrants' Depreciation and Net Income is 0.24. Overlapping area represents the amount of variation of Depreciation that can explain the historical movement of Net Income in the same time period over historical financial statements of Biofrontera Warrants, assuming nothing else is changed. The correlation between historical values of Biofrontera Warrants' Depreciation and Net Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Depreciation of Biofrontera Warrants are associated (or correlated) with its Net Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Income has no effect on the direction of Depreciation i.e., Biofrontera Warrants' Depreciation and Net Income go up and down completely randomly.

Correlation Coefficient

0.24
Relationship DirectionPositive 
Relationship StrengthVery Weak

Depreciation

Depreciation indicates how much of Biofrontera Warrants value has been used up. For tax purposes Biofrontera Warrants can deduct the cost of the tangible assets it purchases as business expenses. However, Biofrontera Warrants must depreciate these assets in accordance with IRS rules about how and when the deduction may be taken, and how long it will last. The systematic allocation of the cost of a tangible asset over its useful life.

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in Biofrontera Warrants financial statement analysis. It represents the amount of money remaining after all of Biofrontera Warrants operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.
Most indicators from Biofrontera Warrants' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Biofrontera Warrants current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biofrontera Warrants. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
For more information on how to buy Biofrontera Stock please use our How to Invest in Biofrontera Warrants guide.At this time, Biofrontera Warrants' Tax Provision is fairly stable compared to the past year. Selling General Administrative is likely to climb to about 35.1 M in 2025, despite the fact that Enterprise Value Over EBITDA is likely to grow to (394.37).
 2022 2023 2024 2025 (projected)
Depreciation And Amortization1.2M1.1M1.1M944.9K
Interest Income175K168K71K88.6K

Biofrontera Warrants fundamental ratios Correlations

-0.370.680.560.490.14-0.56-0.17-0.480.910.670.98-0.320.940.3-0.22-0.17-0.50.560.34-0.080.740.160.99-0.280.89
-0.37-0.65-0.31-0.98-0.540.970.830.8-0.40.21-0.481.0-0.46-0.15-0.530.950.83-0.58-0.890.95-0.47-0.6-0.430.63-0.4
0.68-0.650.640.730.45-0.73-0.7-0.740.670.00.76-0.640.770.580.51-0.6-0.750.490.79-0.510.790.350.74-0.760.59
0.56-0.310.640.430.79-0.32-0.51-0.060.250.230.56-0.330.450.820.21-0.4-0.110.270.58-0.220.780.740.57-0.810.16
0.49-0.980.730.430.6-0.97-0.81-0.810.48-0.080.6-0.970.580.290.47-0.93-0.810.540.9-0.910.620.630.55-0.660.47
0.14-0.540.450.790.6-0.42-0.67-0.11-0.15-0.10.21-0.570.120.740.4-0.73-0.10.060.72-0.620.590.960.16-0.83-0.21
-0.560.97-0.73-0.32-0.97-0.420.750.87-0.610.04-0.660.95-0.65-0.13-0.410.850.9-0.67-0.840.84-0.55-0.47-0.620.55-0.62
-0.170.83-0.7-0.51-0.81-0.670.750.58-0.160.53-0.260.87-0.23-0.36-0.840.90.68-0.54-0.950.84-0.42-0.69-0.250.9-0.11
-0.480.8-0.74-0.06-0.81-0.110.870.58-0.680.13-0.590.78-0.69-0.08-0.450.670.96-0.46-0.640.7-0.5-0.07-0.540.34-0.68
0.91-0.40.670.250.48-0.15-0.61-0.16-0.680.480.91-0.350.940.05-0.1-0.14-0.70.620.28-0.10.57-0.130.92-0.120.99
0.670.210.00.23-0.08-0.10.040.530.130.480.60.270.520.08-0.850.370.210.03-0.30.410.35-0.090.60.310.5
0.98-0.480.760.560.60.21-0.66-0.26-0.590.910.6-0.440.960.34-0.13-0.29-0.590.550.45-0.220.780.20.99-0.350.88
-0.321.0-0.64-0.33-0.97-0.570.950.870.78-0.350.27-0.44-0.41-0.17-0.580.960.81-0.58-0.910.96-0.45-0.63-0.390.66-0.35
0.94-0.460.770.450.580.12-0.65-0.23-0.690.940.520.96-0.410.35-0.06-0.28-0.660.440.38-0.210.810.070.94-0.280.91
0.3-0.150.580.820.290.74-0.13-0.36-0.080.050.080.34-0.170.350.28-0.340.0-0.250.42-0.190.810.540.3-0.69-0.06
-0.22-0.530.510.210.470.4-0.41-0.84-0.45-0.1-0.85-0.13-0.58-0.060.28-0.66-0.530.220.69-0.630.150.35-0.13-0.71-0.16
-0.170.95-0.6-0.4-0.93-0.730.850.90.67-0.140.37-0.290.96-0.28-0.34-0.660.68-0.38-0.920.98-0.48-0.74-0.230.75-0.13
-0.50.83-0.75-0.11-0.81-0.10.90.680.96-0.70.21-0.590.81-0.660.0-0.530.68-0.65-0.70.69-0.43-0.12-0.570.43-0.69
0.56-0.580.490.270.540.06-0.67-0.54-0.460.620.030.55-0.580.44-0.250.22-0.38-0.650.55-0.350.130.240.61-0.380.63
0.34-0.890.790.580.90.72-0.84-0.95-0.640.28-0.30.45-0.910.380.420.69-0.92-0.70.55-0.860.540.720.42-0.890.23
-0.080.95-0.51-0.22-0.91-0.620.840.840.7-0.10.41-0.220.96-0.21-0.19-0.630.980.69-0.35-0.86-0.35-0.64-0.150.62-0.11
0.74-0.470.790.780.620.59-0.55-0.42-0.50.570.350.78-0.450.810.810.15-0.48-0.430.130.54-0.350.470.74-0.610.5
0.16-0.60.350.740.630.96-0.47-0.69-0.07-0.13-0.090.2-0.630.070.540.35-0.74-0.120.240.72-0.640.470.17-0.78-0.17
0.99-0.430.740.570.550.16-0.62-0.25-0.540.920.60.99-0.390.940.3-0.13-0.23-0.570.610.42-0.150.740.17-0.340.89
-0.280.63-0.76-0.81-0.66-0.830.550.90.34-0.120.31-0.350.66-0.28-0.69-0.710.750.43-0.38-0.890.62-0.61-0.78-0.34-0.03
0.89-0.40.590.160.47-0.21-0.62-0.11-0.680.990.50.88-0.350.91-0.06-0.16-0.13-0.690.630.23-0.110.5-0.170.89-0.03
Click cells to compare fundamentals

Biofrontera Warrants Account Relationship Matchups

Biofrontera Warrants fundamental ratios Accounts

202020212022202320242025 (projected)
Total Assets24.1M53.2M50.9M27.9M22.1M27.6M
Other Current Liab2.9M9.9M11.7M4.6M9.6M7.9M
Total Current Liabilities4.4M13.8M20.9M18.1M12.0M14.9M
Total Stockholder Equity5.8M11.3M23.9M4.8M4.4M3.7M
Property Plant And Equipment Net370K267K1.6M1.7M983K998.8K
Net Debt(8.1M)(24.5M)(15.9M)4.1M(983K)(1.0M)
Retained Earnings(41.2M)(78.9M)(79.5M)(99.7M)(117.4M)(123.3M)
Accounts Payable1.5M658K1.3M8.9M1.9M2.9M
Cash8.1M24.5M17.2M1.3M5.9M8.6M
Non Current Assets Total4.6M6.8M7.7M4.9M1.4M1.3M
Non Currrent Assets Other323K3.1M3.1M482K383K363.9K
Cash And Short Term Investments8.1M24.5M27.8M1.4M5.9M10.0M
Net Receivables3.3M3.8M7.4M5.2M5.3M5.5M
Common Stock Shares Outstanding580M855.2M1.1B1.5B5.5B5.8B
Liabilities And Stockholders Equity24.1M53.2M50.9M27.9M22.1M27.6M
Non Current Liabilities Total13.9M28.0M6.1M5.1M5.6M5.4M
Inventory7.1M4.5M7.2M10.9M6.6M6.2M
Other Current Assets1.1M13.6M810K5.6M2.8M4.6M
Other Stockholder Equity47.0M90.2M103.4M104.4M121.8M91.1M
Total Liab18.3M41.9M27.0M23.1M17.7M24.9M
Net Invested Capital5.8M11.3M23.9M8.7M8.5M12.2M
Property Plant And Equipment Gross661K673K1.6M2.3M983K1.3M
Total Current Assets19.6M46.4M43.1M23.1M20.7M23.5M
Capital Stock8K17K27K2K9K11.6K
Non Current Liabilities Other13.9M5.6M21K37K23K21.9K
Net Working Capital15.2M32.6M22.2M5.0M8.7M12.7M
Intangible Assets3.9M3.5M3.0M2.6M35K33.3K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Biofrontera Stock Analysis

When running Biofrontera Warrants' price analysis, check to measure Biofrontera Warrants' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biofrontera Warrants is operating at the current time. Most of Biofrontera Warrants' value examination focuses on studying past and present price action to predict the probability of Biofrontera Warrants' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biofrontera Warrants' price. Additionally, you may evaluate how the addition of Biofrontera Warrants to your portfolios can decrease your overall portfolio volatility.